Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2024.4381
Abstract: Key Points Question Does the addition of lenvatinib to ifosfamide and etoposide (IE) improve treatment outcomes in children and young adults with relapsed or refractory osteosarcoma? Findings In this randomized clinical trial including 81 patients,… read more here.
Keywords: young adults; lenvatinib plus; adults relapsed; plus ifosfamide ... See more keywords
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood.2023021567
Abstract: Key Points • Tisagenlecleucel responses in patients with r/r FL remain highly durable a year after primary analysis; no new safety signals were observed.• Low levels of LAG3+CD3+ exhausted T cells and higher levels of… read more here.
Keywords: refractory follicular; tisagenlecleucel adults; adults relapsed; relapsed refractory ... See more keywords